Pharma Mar, S.A. (OTCMKTS:PHMMF) Short Interest Up 116.3% in October

Pharma Mar, S.A. (OTCMKTS:PHMMF) was the target of a large growth in short interest in the month of October. As of October 31st, there was short interest totalling 26,600 shares, a growth of 116.3% from the October 15th total of 12,300 shares. Based on an average daily trading volume, of 100 shares, the days-to-cover ratio is currently 266.0 days.

Wall Street Analysts Forecast Growth

Separately, Chardan Capital upgraded Pharma Mar to a “strong-buy” rating in a research report on Thursday, August 1st.

Pharma Mar Stock Performance

Pharma Mar stock opened at $75.00 on Friday. The company has a debt-to-equity ratio of 0.14, a quick ratio of 2.01 and a current ratio of 2.55. Pharma Mar has a one year low of $26.85 and a one year high of $75.00. The business has a 50 day simple moving average of $60.04 and a 200 day simple moving average of $42.61.

About Pharma Mar

Pharma Mar, SA, a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally. The company operates through Oncology and RNA Interference segments.